Filing Details
- Accession Number:
- 0001641172-25-017630
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-02 17:49:40
- Reporting Period:
- 2025-07-02
- Filing Date:
- 2025-07-02
- Accepted Time:
- 2025-07-02 17:49:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 2010788 | Exozymes Inc. | EXOZ | Biological Products, (No Disgnostic Substances) (2836) | 834550057 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2030840 | Michael Heltzen | C/O 750 Royal Oaks Drive, Suite 106 Monrovia CA 91016 | Chief Executive Officer | No | Yes | No | No |
Transaction Summary
| Purchased: | 1,040 shares | Avg. Price: $10.22 | Total Value: $10,628.80 |
| Number of Shares After Transactions: | 10,629 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-07-02 | 1,040 | $10.22 | 10,629 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
